Latham Watkins Represents atai Life Sciences in Term Loan Facility for Up to $175 Million from Hercules Capital
atai Life Sciences N.V. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, has announced that the company has entered into a term loan facility for up to $175 million with Hercules Capital, Inc. (NYSE: HTGC). Latham Watkins LLP represents atai in the transaction with a team led […] The post Latham Watkins Represents atai Life Sciences in Term Loan Facility for Up to $175 Million from Hercules Capital appeared first on Legal Desire .
Latham Watkins Represents atai Life Sciences in Term Loan Facility for Up to $175 Million from Hercules Capital
atai Life Sciences N.V. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, has announced that the company has entered into a term loan facility for up to $175 million with Hercules Capital, Inc. (NYSE: HTGC). Latham Watkins LLP represents atai in the transaction with a team led […] The post Latham Watkins Represents atai Life Sciences in Term Loan Facility for Up to $175 Million from Hercules Capital appeared first on Legal Desire .